Anthony J. Culyer
University of York
Public economicsBusinessHealth careEconomicsMedicine
What is this?
Publications 623
#1Paul AnandH-Index: 22
#2Laurence RoopeH-Index: 5
Last. Ronald SmithH-Index: 46
view all 4 authors...
This paper offers an approach to assessing quality-of-life, based on Sen's (1985) theory, which it uses to understand loss in quality-of-life due to mobility-impairment. Specifically, it provides a theoretical analysis which is able to account for the possibility that some functionings may increase when a person's capabilities decrease, if substitution effects are large enough. We then develop novel data consistent with our theoretical Senian framework that permits comparison of quality-of-life ...
#1Laura DowneyH-Index: 3
Last. Miqdad AsariaH-Index: 14
view all 16 authors...
#1Wanrudee Isaranuwatchai (U of T: University of Toronto)H-Index: 4
#2Yot Teerawattananon (NUS: National University of Singapore)H-Index: 4
Last. Jesse B. Bump (Harvard University)H-Index: 8
view all 19 authors...
Wanrudee Isaranuwatchai and colleagues highlight the importance of local context in making decisions about implementing interventions for preventing non-communicable diseases
#1Yot Teerawattananon (Health Intervention and Technology Assessment Program)H-Index: 29
#2Alia Cg Luz (Health Intervention and Technology Assessment Program)
Last. Kalipso Chalkidou (Imperial College London)H-Index: 21
view all 4 authors...
A trend towards charging for access to research findings, tools and databases is becoming more prominent globally. But charging for the use of research tools and databases that are vital to research supporting national and international policy development might be unjustified. Financial barriers to accessing these tools and databases disproportionately affect low- and middle-income countries, who may have greater need for information that fuels research in their areas of concern. However, changi...
The article by Oortwijn, Jansen, and Baltussen (OJB) is much more important than it appears because, in the absence of any good general theory of “evidence-informed deliberative processes” (EDP) and limited evidence of how they might be shaped and work in institutionalising health technology assessment (HTA), the best approach seems to be to accumulate the experience of a variety of countries, preferably systematically, from which some general principles might subsequently be inferred. This comm...
#1Kalipso ChalkidouH-Index: 21
#2Anthony J. Culyer (Ebor: University of York)H-Index: 41
1 CitationsSource
#1Wanrudee Isaranuwatchai (U of T: University of Toronto)H-Index: 4
#2Rachel A. Archer (Health Intervention and Technology Assessment Program)H-Index: 1
Last. Anthony J. Culyer (Ebor: University of York)H-Index: 41
view all 3 authors...
#1Niki O'Brien (Imperial College London)
#2Ryan Li (Imperial College London)H-Index: 10
Last. Kalipso Chalkidou (Imperial College London)H-Index: 8
view all 7 authors...
The World Health Organization (WHO) resolution calling on Member States to work towards achieving universal health coverage (UHC) has increased the need for prioritizing health spending. Such need will soon accelerate as low- and middle-income countries transition from external aid. Countries will have to make difficult decisions on how best to integrate and finance previously donor-funded technologies and health services into their UHC packages in ways that are equitable, and operationally and ...
Abrishami, Oortwijn, and Hofman (AOH) attribute to me a position I do not hold and an argument I did not make. The purpose of this note is make clear what my position actually is and to clarify the main differences between health technology assessment (HTA) and cost-effectiveness analysis (CEA).
#1Abualbishr Alshreef (University of Sheffield)H-Index: 4
#2Kim MacQuilkan (University of the Witwatersrand)H-Index: 1
Last. Ijeoma Edoka (University of the Witwatersrand)H-Index: 4
view all 12 authors...
Abstract Objectives Transferability of economic evaluations to low- and middle-income countries through adaptation of models is important; however, several methodological and practical challenges remain. Given its significant costs and the quality-of-life burden to patients, adjuvant treatment of early breast cancer was identified as a priority intervention by the South African National Department of Health. This study assessed the cost-effectiveness of docetaxel and paclitaxel-containing chemot...
1 CitationsSource